Remission Rate Equal in Antirheumatic Drugs, Anti-TNF Drugs in JaSTAR’s Interim Analysis

April 26, 2012
In a study to compare the triple combination therapy of disease modifying antirheumatic drugs (DMARDs) with anti-TNF drug therapy in patients who had been diagnosed with rheumatoid arthritis (RA) within the last three years, the remission rates of both pharmacotherapies...read more